The Hpv Vaccine – are You Confused?

by Rachel on April 21, 2010

In recent weeks, setting the vaccine against HPV have often been fanfare as newspapers, blogs and medical journals afraid of the media are inundated with conflicting opinions. While the public wants information about the vaccine in simple words and clear that the potential benefits and limitations of the vaccine a little hard to see in black and white. Some issues that have dominated the media about the vaccine are: Is the vaccine safe? – The recent concerns about the safety of Gardasil have many parents worried. No doubt, no negative impact will be carefully monitored to ensure that the vaccine has a good safety profile. As a parent, I can understand these concerns, but as a physician, I have the opportunity to look more closely at the safety profile was taken Gardasil. To date, nearly 8 million doses of Gardasil have been administered, and adverse effects were analyzed in detail by medical experts to VAERS (Vaccine Adverse Effects Reporting System), a branch of the CDC. So far, no consistent pattern emerged from the reports is to show that the vaccine is directly responsible for one of the side effects observed. Therefore, to continue to find both the FDA and CDC, Gardasil, a vaccine safe and effective with the advantages far outweigh the risks. Does the disease cause substitution of vaccines? – The August 2008 issue of The New England Journal of Medicine raised concerns about the vaccine against HPV. One was the concern that Gardasil offers protection against two major strains of HPV that cause HPV types less dangerous provide an opportunity more often the cause of the disease. This phenomenon is known as replacement disease.’s disease replacement has been seen, for example, if the vaccine Prevnar was introduced in 2000 against diseases respiratory disease caused by bacteria in the fight against pneumococcal disease in children. And although there are some cases of the disease by the types of pneumococci that were not caused by the vaccine coverage, they were insignificant when millions of lives were saved by the vaccine against it. With the vaccine against HPV, there are currently few reports referring to the development of HPV types not covered vaccine, but they were of no clinical significance. What is the best time to vaccinate? – People treated Revisited – Public Health, no. Therefore, when making recommendations for an entire generation of American women, policymakers must consider several factors in the least costly to maximize the benefits of a drug or vaccine to reach the load. The vaccine against HPV is preventive in nature, meaning it can not cure existing HPV infections. Therefore, the point of to public health, it is preferable to administer the vaccine to girls aged 11-12 years before their first intercourse than later (catch-up vaccination is currently recommended between the ages of 13-26 years) have been at were exposed to the virus. It’s also time to go to middle school children to their doctors or clinics to receive other recommended shots, making it easier to offer the Vaccination against HPV. Vaccinating girls at this age to give the best protection because it will reduce the consequences of HPV disease in later life, including the possibility of exposure due to unforeseen events such as the infidelity in a relationship long term or new sexual partners after widowhood or divorce. When vaccination affect natural immunity – Whether natural immunity against a given disease is acquired when a person on the specific organism that is exposed to the disease caused. Obviously, there are significant risks – for example, benefit from natural immunity to polio, you would be paralyzed in the process. The immunity acquired by vaccination causes a person to develop antibodies without produce the disease in most cases. In the case of HPV, it is not clear that natural infections provide adequate protection of life, but studies have shown that vaccine antibody levels that are almost ten Once antibody titers higher than those produced by natural infection product. If this increased immunity leads to stronger and more effective is not yet known. Is it true that there is no evidence that the vaccine to reduce the rate of cancer of the cervix uteri? – Very few HPV infections lead to cancer of the cervix, over 90% of infections clear on their own. Among those who remain is the delay between acquisition of HPV infection and development of cervical cancer of the uterus nearly 20 years. Therefore, young women who have been vaccinated, are now aged 35-50, the approach to the summit of the pass before we have any meaningful results. However, there is sufficient scientific evidence for the theory that the vaccine can prevent cervical cancer support. Clinical studies on alternative views of cancer – conditions if left alone in invasive cancer of the cervix inevitably progress – as parameters of the study. In the case of the vaccine against HPV, they look for abnormal cells or a significant precancerous lesions in women who have been vaccinated. The vaccine has been found for the development of these abnormal cells by preventing HPV types covered by it. It was expected that vaccine to prevent cervical cancer. Of course, nobody can predict with accuracy, that the vaccine works in the “real world” in the coming decades. It is an act of faith to some extent, but a leap year that most of us want, because we have faith in medical miracles, we will have served so well over the years. © 2008 Dr. Shobha S. Krishnan, MD Author Bio Dr. Shobha S. Krishnan, MD, is a medical staff of Columbia University Barnard College Health Services. A specialist gynecologist and dentist, she also worked as a physician to monitor the federal Centers for Disease Control and Prevention. Prior to joining Barnard, she was in private practice for 10 years. In addition Dr. Krishnan has worked as a doctor at the Institute on Aging and as Chief Resident in the Department of Family Medicine at St. Vincent Hospital, Indianapolis. His new book: The vaccine against HPV controversy: sex , Cancer, God and politics – a guide for parents, women, men and youth is scheduled for 30 August 2008 Published by Greenwood Publications. The book presents the latest information about the vaccine without the influence pharmaceutical companies or other interest groups.

http://www. Greenwood. com/catalog/C35011. aspx for more information. The book can be purchased on Amazon. com, Barnes and Noble. com and borders. com.

Leave a Comment

Previous post:

Next post: